Vaxxinity, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q3 2020 to Q4 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Vaxxinity, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q3 2020 to Q4 2023.
  • Vaxxinity, Inc. Share-based Payment Arrangement, Expense for the quarter ending December 31, 2023 was $1.08M, a 54.1% decline year-over-year.
  • Vaxxinity, Inc. Share-based Payment Arrangement, Expense for the twelve months ending December 31, 2023 was $7.51M, a 13.8% decline year-over-year.
  • Vaxxinity, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $7.51M, a 13.8% decline from 2022.
  • Vaxxinity, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $8.71M, a 71.3% decline from 2021.
  • Vaxxinity, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $30.4M, unchanged from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2023 $7.51M $1.08M -$1.27M -54.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-27
Q3 2023 $8.78M $1.77M -$588K -24.9% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-08
Q2 2023 $9.37M $2.43M +$607K +33.2% Apr 1, 2023 Jun 30, 2023 10-Q 2023-08-09
Q1 2023 $8.76M $2.23M +$47K +2.16% Jan 1, 2023 Mar 31, 2023 10-Q 2023-05-09
Q4 2022 $8.71M $2.35M -$22.4M -90.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-27
Q3 2022 $31.1M $2.36M +$893K +61% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-08
Q2 2022 $30.2M $1.83M +$1.02M +128% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-09
Q1 2022 $29.2M $2.18M -$1.26M -36.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 $30.4M $24.7M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-27
Q3 2021 $1.46M $0 0% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-10
Q2 2021 $802K Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-11
Q1 2021 $3.44M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-09
Q3 2020 $1.46M Jul 1, 2020 Sep 30, 2020 10-Q 2021-12-23
* An asterisk sign (*) next to the value indicates that the value is likely invalid.